Primary Site >> Liver Cancer
Gene >> STARD13
| 1. | |||||||||||
| Journal: | J Biol Chem. 2003 Mar 21;278(12):10824-30. | ||||||||||
| Title: | Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinoma. | ||||||||||
| Author: | Ching, Yick-Pang|Wong, Chun-Ming|Chan, Shing-Fai|Leung, Thomas Ho-Yin|Ng, David Chi-Heng|Jin, Dong-Yan|Ng, Irene Oi-lin | ||||||||||
| PMID: | 12531887 | ||||||||||
| 2. | |||||||||||
| Journal: | Biochem Biophys Res Commun. 2004 Mar 19;315(4):781. | ||||||||||
| Title: | Rho GTPase activating protein cDNA on chromosome 13q12 is the deleted in liver cancer (DLC2) gene. | ||||||||||
| Author: | Popescu, Nicholas C|Durkin, Marian E | ||||||||||
| PMID: | 14985079 | ||||||||||
| 3. | |||||||||||
| Journal: | Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15207-12. | ||||||||||
| Title: | Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity. | ||||||||||
| Author: | Leung, Thomas Ho-Yin|Ching, Yick-Pang|Yam, Judy Wai Ping|Wong, Chun-Ming|Yau, Tai-On|Jin, Dong-Yan|Ng, Irene Oi-Lin | ||||||||||
| PMID: | 16217026 | ||||||||||
| 4. | |||||||||||
| Journal: | FEBS Lett. 2006 Jan 9;580(1):191-8. | ||||||||||
| Title: | Mitochondrial targeting of growth suppressor protein DLC2 through the START domain. | ||||||||||
| Author: | Ng, David Chi-Heng|Chan, Shing-Fai|Kok, Kin Hang|Yam, Judy Wai Ping|Ching, Yick-Pang|Ng, Irene Oi-Lin|Jin, Dong-Yan | ||||||||||
| PMID: | 16364308 | ||||||||||
| 5. | |||||||||||
| Journal: | Proteins. 2007 Jun 1;67(4):1154-66. | ||||||||||
| Title: | Solution structures, dynamics, and lipid-binding of the sterile alpha-motif domain of the deleted in liver cancer 2. | ||||||||||
| Author: | Li, Hongyan|Fung, King-Leung|Jin, Dong-Yan|Chung, Stephen S M|Ching, Yick-Pang|Ng, Irene Oi-lin|Sze, Kong-Hung|Ko, Ben C B|Sun, Hongzhe | ||||||||||
| PMID: | 17380510 | ||||||||||
| 6. | |||||||||||
| Journal: | BMC Cancer. 2008 Jul 23;8:205. | ||||||||||
| Title: | Underexpression of deleted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinoma. | ||||||||||
| Author: | Xiaorong, Li|Wei, Wu|Liyuan, Qian|Kaiyan, Yang | ||||||||||
| PMID: | 18651974 | ||||||||||
| 7. | |||||||||||
| Journal: | PLoS One. 2009 Aug 10;4(8):e6566. | ||||||||||
| Title: | Deleted in liver cancer 2 (DLC2) was dispensable for development and its deficiency did not aggravate hepatocarcinogenesis. | ||||||||||
| Author: | Yau, Tai On|Leung, Thomas Ho Yin|Lam, Sandra|Cheung, Oi Fung|Tung, Edmund Kwok Kwan|Khong, Pek Lan|Lam, Amy|Chung, Sookja|Ng, Irene Oi Lin | ||||||||||
| PMID: | 19668331 | ||||||||||
| 8. | |||||||||||
| Journal: | Liver Int. 2010 Oct;30(9):1315-23. | ||||||||||
| Title: | Deleted in liver cancer 2 suppresses cell growth via the regulation of the Raf-1-ERK1/2-p70S6K signalling pathway. | ||||||||||
| Author: | Leung, Thomas Ho-Yin|Yam, Judy Wai-Ping|Chan, Lo Kong|Ching, Yick-Pang|Ng, Irene Oi-Lin | ||||||||||
| PMID: | 20629949 | ||||||||||
| 9. | |||||||||||
| Journal: | Oncol Rep. 2012 Aug;28(2):511-8. | ||||||||||
| Title: | DLC2/StarD13 plays a role of a tumor suppressor in astrocytoma. | ||||||||||
| Author: | El-Sitt, Sally|Khalil, Bassem D|Hanna, Samer|El-Sabban, Marwan|Fakhreddine, Najla|El-Sibai, Mirvat | ||||||||||
| PMID: | 22614672 | ||||||||||
| 10. | |||||||||||
| Journal: | J Recept Signal Transduct Res. 2013;33(1):10-3. | ||||||||||
| Title: | The STAR of the DLC family. | ||||||||||
| Author: | El-Sitt, Sally|El-Sibai, Mirvat | ||||||||||
| PMID: | 23316797 | ||||||||||
| 11. | |||||||||||
| Journal: | Oncol Rep. 2014 Jan;31(1):505-15. | ||||||||||
| Title: | Effect of StarD13 on colorectal cancer proliferation, motility and invasion. | ||||||||||
| Author: | Nasrallah, Anita|Saykali, Bechara|Al Dimassi, Saleh|Khoury, Nathalie|Hanna, Samer|El-Sibai, Mirvat | ||||||||||
| PMID: | 24253896 | ||||||||||
| 12. | |||||||||||
| Journal: | Biotechnol Lett. 2017 Feb;39(2):207-217. | ||||||||||
| Title: | STARD13 promotes hepatocellular carcinoma apoptosis by acting as a ceRNA for Fas. | ||||||||||
| Author: | Zhang, Hai|Wang, Fang|Hu, Yahua | ||||||||||
| PMID: | 27844181 | ||||||||||
| 13. | |||||||||||
| Journal: | Onco Targets Ther. 2018 Aug 31;11:5371-5381. | ||||||||||
| Title: | STARD13 is positively correlated with good prognosis and enhances 5-FU sensitivity via suppressing cancer stemness in hepatocellular carcinoma cells. | ||||||||||
| Author: | Gao, Fei|Yu, Xiaolin|Meng, Rongqin|Wang, Jisheng|Jia, Lin | ||||||||||
| PMID: | 30214243 | ||||||||||